In the adjusted model , each @-SD increase in LDL-C variability ( by ASV ) increased the risk of any coronary event by @ % ( hazard ratio -LSB- HR -RSB- : @ ; @ % confidence interval -LSB- CI -RSB- : @ to @ ; p < @ ) , any cardiovascular event by @ % ( HR : @ ; @ % CI : @ to @ ; p < @ ) , death by @ % ( HR : @ ; @ % CI : @ to @ ; p < @ ) , myocardial infarction by @ % ( HR : @ ; @ % CI : @ to @ ; p = @ ) , and stroke by @ % ( HR : @ ; @ % CI : @ to @ ; p = @ ) , independent of treatment effect and achieved LDL-C levels .